Skip to main content

News

We are focused on helping people live healthier, happier and longer by providing reliable healthcare solutions through innovation, technological advancement and commitment to quality.

 

Cordlife Press Release

10 November 2005

CyGenics Ltd and Cell Therapies to Collaborate on T-cell Clinical Trials

07 November 2005

CyGenics takes 51% equity in an Australian cord blood banking business

06 October 2005

CyGenics secures exclusive licence on enhanced T cell production technologies from the Brigham and Women’s Hospital Exclusive worldwide licence from Harvard Medical School teaching affiliate

30 September 2005

Annual Report, 2005

13 September 2005

Cord Blood Misconceptions Dispelled

06 September 2005

CordLife is Southeast Asia’s First AABB Accredited Cord Blood Bank

31 August 2005

CyGenics reports a 40 per cent increase in revenue

01 August 2005

CyGenics Quarterly Newsletter August 2005

08 July 2005

Change Of Director's Interest Notice

04 July 2005

Manager of Company Announcements Australian Stock Exchange

20 June 2005

CyGenics forms new US subsidiary CytoVations to acquire and develop cell technology

16 May 2005

CyGenics strengthens Melbourne operations